| Entry |
|
|---|
| Name |
CaMK2-p38-MK2-ALOX5 pathway
|
|---|
| Definition |
CAMK2 -> p38 -> MK2 -- ALOX5(cyto) -> ALOX5(nuclear) |
|---|
| Expanded |
(815,816,817,818) -> (1432,5600,5603,6300) -> 9261 -- 240 -> 240 |
|---|
| Class |
|
|---|
| Type |
Reference
|
|---|
| Pathway |
|
|---|
| Gene |
| 815 | CAMK2A; calcium/calmodulin dependent protein kinase II alpha |
| 816 | CAMK2B; calcium/calmodulin dependent protein kinase II beta |
| 817 | CAMK2D; calcium/calmodulin dependent protein kinase II delta |
| 818 | CAMK2G; calcium/calmodulin dependent protein kinase II gamma |
| 1432 | MAPK14; mitogen-activated protein kinase 14 |
| 5600 | MAPK11; mitogen-activated protein kinase 11 |
| 5603 | MAPK13; mitogen-activated protein kinase 13 |
| 6300 | MAPK12; mitogen-activated protein kinase 12 |
| 9261 | MAPKAPK2; MAPK activated protein kinase 2 |
| 240 | ALOX5; arachidonate 5-lipoxygenase |
|
|---|
| Reference |
|
|---|
| Authors |
Cai B, Kasikara C, Doran AC, Ramakrishnan R, Birge RB, Tabas I |
|---|
| Title |
MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Zhang J, Ding W, Zhao M, Liu J, Xu Y, Wan J, Wang M |
|---|
| Title |
Mechanisms of efferocytosis in determining inflammation resolution: Therapeutic potential and the association with cardiovascular disease. |
|---|
| Journal |
|
|---|
| LinkDB |
|
|---|
